CHIPS-(28-149)



CHIPS-(28-149)

A1AA1F2FF2T3TT3F4FF4E5EE5P6PP6F7FF7P8PP8T9TT9N10NN10E11EE11E12EE12I13II13E14EE14S15SS15N16NN16K17KK17K18KK18M19MM19L20LL20E21EE21K22KK22E23EE23K24KK24A25AA25Y26YY26K27KK27E28EE28S29SS29F30FF30K31KK31N32NN32S33SS33G34GG34L35LL35P36PP36T37TT37T38TT38L39LL39G40GG40K41KK41L42LL42D43DD43E44EE44R45RR45L46LL46R47RR47... and 75 more residue(s)...... and 75 more residue(s)

SMILES None
InChIKey None
Sequence AFTFEPFPTNEEIESNKKMLEKEKAYKESFKNSGLPTTLGKLDERLRNYLKKGTKNSAQFEKMVILTENKGYYTVYLNTPLAEDRKNVELLGKMYKTYFFKKGESKSSYVINGPGKTNEYAY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CHIPS-(28-149)

A1AA1F2FF2T3TT3F4FF4E5EE5P6PP6F7FF7P8PP8T9TT9N10NN10E11EE11E12EE12I13II13E14EE14S15SS15N16NN16K17KK17K18KK18M19MM19L20LL20E21EE21K22KK22E23EE23K24KK24A25AA25Y26YY26K27KK27E28EE28S29SS29F30FF30K31KK31N32NN32S33SS33G34GG34L35LL35P36PP36T37TT37T38TT38L39LL39G40GG40K41KK41L42LL42D43DD43E44EE44R45RR45L46LL46R47RR47... and 75 more residue(s)...... and 75 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.